The US Centers for Disease Control and Prevention (CDC) in its weekly update today reported 42 measles cases, some tied to a ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

The data show a continuation of a decades-old trend toward increasing US excess deaths, mainly among working-age adults, ...

The CDC is still recommending COVID vaccination for children ages 6 months to 17 years who are moderately or severely ...

Despite being the leading cause of acute gastroenteritis  worldwide, there are currently no vaccines for norovirus.

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Cambodia's ministry of health has reported its fourth fatal human H5N1 avian flu case of the year, which involves an ...

Long-COVID symptoms were based on caregiver-reported symptoms lasting at least 90 days after COVID infections; in total 41 ...

A large observational study provides evidence that antibiotics provide no benefit for patients hospitalized with nonsevere ...